Treatment coordination programme

Organ and Stem Cell Transplantation

Name: Organ and Stem Cell Transplantation
Creator: InMedism Editorial Team

Coordination with transplant programmes for eligible patients, subject to clinical, donor, legal and hospital requirements.

Request specialist coordination Browse doctors →

Solid-organ safeguard

Solid-organ transplantation in India is regulated by THOTA.

Clinical eligibility, donor evaluation, legal review and every required approval remain with the registered transplant hospital and competent authorities.

No organ or donor trade

InMedism does not source, sell, purchase, advertise, negotiate or promise human organs or paid donors. Commercial dealing is prohibited and punishable in India.

Kidney, liver and other solid-organ transplantation is governed by the Transplantation of Human Organs and Tissues Act, 1994 (THOTA), its rules and applicable NOTTO or state requirements.
Living-donor identity, age, relationship, medical fitness and free consent must be verified through the authorised hospital process.
When a donor or recipient is a foreign national, the registered hospital must determine and complete the applicable Authorization Committee, relationship-certification and medical-visa requirements before transplantation.
Deceased-donor registration, waiting-list priority and allocation are controlled by the authorised transplant system—not by InMedism.
No enquiry, estimate, travel arrangement or payment guarantees transplant approval, organ allocation, admission or outcome.

NOTTO guidance for foreign citizens ↗THOTA on India Code ↗

HSCT and BMT safeguard

Haematopoietic stem-cell transplantation requires specialist programme review.

Autologous and allogeneic HSCT are distinct from solid-organ transplantation. Organ-allocation and deceased-donor waiting-list language does not apply to these pages.

Use an appropriate haematology transplant programme

The treating programme must confirm the indication, patient fitness, cell source, conditioning plan, laboratory and infection-control pathway, consent and follow-up requirements.

For allogeneic HSCT, donor suitability requires independent medical assessment, HLA and compatibility work-up, infection screening, voluntary informed consent and a safe collection plan.
For autologous HSCT, the patient’s own cells are mobilised, collected, processed, stored and reinfused; donor relationship and organ-allocation processes are not relevant.
Cell identity, collection, processing, storage, transport, traceability and release should follow the treating programme’s quality and safety procedures.
Established HSCT for recognised indications must not be confused with unproven “stem-cell therapy.” Investigational use requires the applicable ethics, clinical-trial and regulatory review.
Cell or stem-cell-derived products that fall within India’s new-drug framework may require CDSCO permissions under the New Drugs and Clinical Trials Rules; the treating institution must determine what applies to the proposed product or protocol.
No enquiry, estimate or travel arrangement confirms candidacy, donor suitability, engraftment or outcome.

ICMR National Guidelines for Hematopoietic Cell Transplantation ↗CDSCO New Drugs and Clinical Trials framework ↗

Coordination pathway

What may be coordinated

The exact pathway depends on diagnosis, records, previous treatment, patient priorities and the hospital’s clinical review.

Transplant-centre consultation
Eligibility and record review
Donor-document guidance
Legal and ethics requirements
Long-term follow-up planning

Share relevant information through the approved process.
Identify an appropriate hospital department or specialist.
Coordinate preliminary review and clarification questions.
Discuss the provider’s proposed plan and estimate.
Plan travel only after appropriate confirmation.

Prepare the case

Records that may support review

Diagnosis, organ-function tests and recent hospital summaries
Blood group and relevant compatibility information
Dialysis or previous transplant records where applicable
Infection screening and current medicines
Potential donor relationship and identity documents only through an approved secure route

Informed discussion

Questions the specialist should clarify

What clinical criteria determine transplant eligibility?
Which donor, legal and authorization requirements apply?
What evaluation is required for the patient and potential donor?
What immunosuppression and long-term monitoring may be needed?
How will follow-up and complications be managed after returning home?

Network capabilities

Related specialties and procedures

Select a pathway for focused information. Availability varies by provider, and listing does not imply suitability for a particular patient.

Heart TransplantationView pathway →Kidney TransplantationView pathway →Liver TransplantationView pathway →Lung TransplantationView pathway →Stem Cell or Bone Marrow TransplantView pathway →

Related specialists

Doctors connected to this programme

Each profile is included because its verified primary specialty aligns with part of this programme. Individual suitability and current availability require case review.

Urology

Dr. Anil Mandhani

Urology, Uro-Oncology & Robotic Surgery

Fortis Memorial Research Institute, GurugramView verified profile →

Haematology & Bone Marrow Transplant

Dr. Dharma Choudhary

Bone Marrow Transplant, Haematology & Haemato-Oncology

BLK-Max Super Speciality Hospital, New DelhiView verified profile →

Editorial review status

Updated 26 August 2026 by the InMedism Editorial Team. This is an editorial source review—not a clinical review or individualized medical advice.

Contextual guidance

Questions patients often ask

These answers provide general coordination information. Questions about diagnosis, risks or treatment require a qualified clinician.

Ask a different question →

Can InMedism confirm transplant eligibility?

No. Eligibility can only be determined by an authorized transplant team after full clinical, legal and donor assessment.

Can an unrelated donor travel for transplantation?

Rules are strict and vary by transplant type and circumstances. The authorized hospital and relevant committees must verify all legal and ethical requirements.

How long will the patient remain in India?

The expected stay depends on evaluation, procedure, recovery and follow-up requirements defined by the transplant team.